Suppr超能文献

复发性甲状腺乳头状癌的临床病理特征

Clinicopathological features of recurrent papillary thyroid cancer.

作者信息

Zhu Jian, Wang Xinli, Zhang Xiaoxuan, Li Peifeng, Hou Haifeng

机构信息

Department of Thyroid and Breast Surgery, General Hospital of Jinan Military Command, Jinan, 250031, China.

Department of Pathology, Affiliated Hospital of Taishan Medical College, Taian, 271000, China.

出版信息

Diagn Pathol. 2015 Jul 14;10:96. doi: 10.1186/s13000-015-0346-5.

Abstract

BACKGROUND

To investigate the clinicopathological features of recurrent papillary thyroid carcinoma (PTC).

METHODS

A retrospective analysis on clinical and pathological data of 34 patients with recurrent PTC was carried out. A total of 281 patients with non-recurrent PTC during the same time period were chosen as the control group.

RESULTS

Patients were divided into three groups according to the pathological subtype. The number of patients belonging to Groups 1, 2, and 3 were 28, 154, and 133, respectively. 78 patients underwent partial or whole thyroidectomy, 151 cases underwent thyroidectomy combining neck regional lymph node dissection, and 86 patients underwent thyroidectomy combining modified or radical neck dissection. Univariate analysis showed that PTC recurrence was associated with tumor size, extrathyroid invasion, initial surgery approach, lymph node metastasis, and pathological subtype (P < 0.05). Patient age, gender, complication with Hashimoto's thyroiditis, and multifocality were unrelated to PTC recurrence (P > 0.05). Multivariate analysis showed that initial surgery approach and pathological subtype perform important functions in PTC recurrence (P < 0.001). Initial surgery approach presented a negative correlation with PTC recurrence (β = -0.320, OR = 0.726). The pathological subtype was also related to PTC recurrence (β = 0.923, OR = 2.517).

CONCLUSION

PTC patients without neck dissection showed greater likelihood of postoperative recurrence. Patients with the tall cell, columnar cell, diffuse sclerosing, and oncocytic variants showed a higher propensity for PTC recurrence after operation compared with those who did not. Tumor volume, extrathyroid invasion, and multiple lymph node metastases at the time of initial operation were also significantly related to postoperative recurrence. Follow-up supervision must be enhanced after initial treatment to mitigate PTC recurrence in susceptible patients. Effective and standard treatments must be adopted immediately after the discovery of recurrence.

摘要

背景

探讨复发性甲状腺乳头状癌(PTC)的临床病理特征。

方法

对34例复发性PTC患者的临床和病理资料进行回顾性分析。选取同期281例非复发性PTC患者作为对照组。

结果

根据病理亚型将患者分为三组。第1、2、3组的患者人数分别为28、154和133例。78例患者接受了部分或全甲状腺切除术,151例患者接受了甲状腺切除术联合颈部区域淋巴结清扫术,86例患者接受了甲状腺切除术联合改良或根治性颈部清扫术。单因素分析显示,PTC复发与肿瘤大小、甲状腺外侵犯、初次手术方式、淋巴结转移和病理亚型有关(P<0.05)。患者年龄、性别、合并桥本甲状腺炎及多灶性与PTC复发无关(P>0.05)。多因素分析显示,初次手术方式和病理亚型在PTC复发中起重要作用(P<0.001)。初次手术方式与PTC复发呈负相关(β=-0.320,OR=0.726)。病理亚型也与PTC复发有关(β=0.923,OR=2.517)。

结论

未行颈部清扫术的PTC患者术后复发可能性更大。与未出现高细胞、柱状细胞、弥漫性硬化和嗜酸细胞变异的患者相比,出现这些变异的患者术后PTC复发倾向更高。初次手术时肿瘤体积、甲状腺外侵犯和多发淋巴结转移也与术后复发显著相关。初始治疗后必须加强随访监测,以降低易感患者的PTC复发率。复发发现后必须立即采取有效和规范的治疗措施。

相似文献

1
Clinicopathological features of recurrent papillary thyroid cancer.
Diagn Pathol. 2015 Jul 14;10:96. doi: 10.1186/s13000-015-0346-5.
3
Significance of multifocality in papillary thyroid carcinoma.
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
5
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.
6
[Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Zhonghua Zhong Liu Za Zhi. 2017 May 23;39(5):361-366. doi: 10.3760/cma.j.issn.0253-3766.2017.05.008.
7
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
8
Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Auris Nasus Larynx. 2016 Feb;43(1):79-83. doi: 10.1016/j.anl.2015.09.005. Epub 2015 Oct 3.

引用本文的文献

2
The Impact of Total Tumor Diameter on Lymph Node Metastasis and Tumor Recurrence in Papillary Thyroid Carcinomas.
Diagnostics (Basel). 2024 Jan 26;14(3):272. doi: 10.3390/diagnostics14030272.
3
Surgical resection of recurrent differentiated thyroid cancer: patterns, detection, staging, and treatment of 683 patients.
Front Endocrinol (Lausanne). 2023 Dec 6;14:1301620. doi: 10.3389/fendo.2023.1301620. eCollection 2023.
4
Association between papillary thyroid carcinoma and lymphocytic thyroiditis: A retrospective study.
Oncol Lett. 2023 Mar 1;25(4):148. doi: 10.3892/ol.2023.13734. eCollection 2023 Apr.
6
AXL, along with PROS1, is overexpressed in papillary thyroid carcinoma and regulates its biological behaviour.
World J Surg Oncol. 2022 Oct 6;20(1):334. doi: 10.1186/s12957-022-02801-0.
7
Transcriptomic signatures associated with autoimmune thyroiditis in papillary thyroid carcinoma and cancer immunotherapy-induced thyroid dysfunction.
Comput Struct Biotechnol J. 2022 May 16;20:2391-2401. doi: 10.1016/j.csbj.2022.05.019. eCollection 2022.
8
I Seed Brachytherapy for Refractory Loco-Regional Recurrence of Non-Anaplastic Thyroid Cancer.
Front Oncol. 2022 Feb 15;12:773708. doi: 10.3389/fonc.2022.773708. eCollection 2022.
10
Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
World J Surg. 2021 Sep;45(9):2769-2776. doi: 10.1007/s00268-021-06185-2. Epub 2021 Jun 7.

本文引用的文献

1
Lateral neck recurrence from papillary thyroid carcinoma: Predictive factors and prognostic significance.
Laryngoscope. 2015 Sep;125(9):2226-31. doi: 10.1002/lary.25094. Epub 2014 Dec 15.
3
Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
Ann Surg Oncol. 2015 Jan;22(1):117-24. doi: 10.1245/s10434-014-3900-6. Epub 2014 Jul 18.
5
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma.
Ann Surg Oncol. 2014 Apr;21(4):1374-8. doi: 10.1245/s10434-013-3428-1. Epub 2013 Dec 24.
7
Euthyroid Graves' orbitopathy and incidental papillary thyroid microcarcinoma.
Hormones (Athens). 2013 Apr-Jun;12(2):298-304. doi: 10.14310/horm.2002.1414.
8
Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Thyroid. 2013 Sep;23(9):1159-64. doi: 10.1089/thy.2012.0595. Epub 2013 Aug 28.
9
Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.
Clin Nucl Med. 2013 Jan;38(1):25-8. doi: 10.1097/RLU.0b013e318279bc65.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验